Adult diarrhea rotavirus (ADRV) is a newly identified strain of noncultivable human group B rotavirus that has been epidemic in the People's Republic of China since 1982. We have used sodium dodecyl sulfatepolyacrylamide gel electrophoresis and Western (immuno-) blot analysis to examine the viral proteins present in the outer and inner capsids of ADRV and compared these with the proteins of a group A rotavirus, SAll. EDTA treatment of double-shelled virions removed the outer capsid and resulted in the loss of three polypeptides of 64, 61, and 41, kilodaltons (kDa). Endo-o-N-acetylglucosaminidase H digestion of doubleshelled virions identified the 41-kDa polypeptide as a glycoprotein. CaCl2 treatment of single-shelled particles removed the inner capsid and resulted in the loss of one polypeptide with a molecular mass of 47 kDa. The remaining core particle had two major structural proteins of 136 and 113 kDa. All of the proteins visualized on sodium dodecyl sulfate-polyacrylamide gel electrophoresis were antigenic by Western blot analysis when probed with convalescent-phase human and animal antisera. A 47-kDa polypeptide was most abundant and was strongly immunoreactive with human sera, animal sera raised against ADRV and against other group B animal rotaviruses (infectious diarrhea of infant rat virus, bovine and porcine group B rotavirus, and bovine enteric syncytial virus) and a monoclonal antibody prepared against infectious diarrhea of infant rat virus. This 47-kDa inner capsid polypeptide contains a common group B pntigen and is similar to the VP6 of the group A rotaviruses. Human convalescent-phase sera also responded to a 41-kDa polypeptide of the outer capsid that seems similar to the VP7 of group A rotavirus. Other polypeptides have been given tentative designations on the basis of similarities to the control preparation of SAll, including a 136-kDa polypeptide designated VP1, a 113-kDa polypeptide designated VP2, 64-and 61-kDa polypeptides designated VP5 and VP5a, and several proteins in the 110-to 72-kDa range that may be VP3, VP4, or related proteins. The lack of cross-reactivity on Western blots between antisera to group A versus group B rotaviruses confirmed that these viruses are antigenically quite distinct.
shelled virions identified the 41-kDa polypeptide as a glycoprotein. CaCl2 treatment of single-shelled particles removed the inner capsid and resulted in the loss of one polypeptide with a molecular mass of 47 kDa. The remaining core particle had two major structural proteins of 136 and 113 kDa. All of the proteins visualized on sodium dodecyl sulfate-polyacrylamide gel electrophoresis were antigenic by Western blot analysis when probed with convalescent-phase human and animal antisera. A 47-kDa polypeptide was most abundant and was strongly immunoreactive with human sera, animal sera raised against ADRV and against other group B animal rotaviruses (infectious diarrhea of infant rat virus, bovine and porcine group B rotavirus, and bovine enteric syncytial virus) and a monoclonal antibody prepared against infectious diarrhea of infant rat virus. This 47-kDa inner capsid polypeptide contains a common group B pntigen and is similar to the VP6 of the group A rotaviruses. Human convalescent-phase sera also responded to a 41-kDa polypeptide of the outer capsid that seems similar to the VP7 of group A rotavirus. Other polypeptides have been given tentative designations on the basis of similarities to the control preparation of SAll, including a 136-kDa polypeptide designated VP1, a 113-kDa polypeptide designated VP2, 64-and 61-kDa polypeptides designated VP5 and VP5a, and several proteins in the 110-to 72-kDa range that may be VP3, VP4, or related proteins. The lack of cross-reactivity on Western blots between antisera to group A versus group B rotaviruses confirmed that these viruses are antigenically quite distinct.
The rotaviruses have recently been subdivided into groups that share the characteristic rotavirus morphology but can be distinguished by RNA electropherotype and by group-specific antigens (3) . The group A rotaviruses are recognized as a major cause of diarrhea in children (12) . The non-group A rotaviruses have been identified in a variety of animal species with diarrhea but have rarely been found in association with human disease (4, 6, 8, 19) . In 1982 and 1983, epidemics of severe, dehydrating diarrhea affecting tens of thousands of adults were reported throughout the People's Republic of China and were traced to a group B rotavirus called adult diarrhea rotavirus (ADRV) (10, 11) . These outbreaks have persisted in the People's Republic of China and have raised many questions concerning the origin of these strains, their relatedness to other rotaviruses, and the prospects that group B rotaviruses might become epidemic in other parts of the world. Work with human isolates of non-group A rotaviruses has been hampered by an inability to grow these viruses in cell culture (lOa). Preliminary cDNA cloning experiments with group B rotaviruses were initiated, * Corresponding author. but neither the gene coding assignments nor the protein structures have been determined (16) .
We have purified ADRV from human stool specimens collected during an outbreak in China and have characterized the virus, with specific emphasis on the viral proteins. Proteins present in the outer capsid, inner capsid, and core have been identified by disruption of double-shelled virus into single-shelled particles and cores. Viral proteins that react with human, animal, and monoclonal antisera have been characterized by using Western (immuno-) blot analysis, and the proteins of ADRV have been compared with those of group A rotaviruses to identify major similarities and differences.
MATERIALS AND METHODS
Rotaviruses and antisera. Fecal specimens containing ADRV were collected from patients in a single outbreak that occurred in Chengde, Hebei Province, the People's Republic of China, in 1987. Specimens that were positive by an enzyme-linked immunosorbent assay for ADRV (25) Virus purification. Group A rotavirus was purified from infected MA104 cells by previously described methods (14) . In brief, rotavirus was released from the cells after three cycles of freezing and thawing followed by sonication for 1 min and then mixed with an equal volume of trichlorotrifluoroethahe (Genetron). The cell lysate was homogenized by shaking, and the phases were separated by centrifugation at 1,100 x g for 10 min. The organic phase was reextracted with an equal volume of Tris-buffered saline (TBS), pH 7.2 (20 mM Tris hydrochloride, 140 mM NaCl, 5 mM KCl, 0.4 mM Na2HPO4, 6 mM glucose, 0.5 mM MgCI2, and 5 mM CaCl2). The aqueous phases were combined, layered onto 1 ml of 30% (wt/vol) sucrose in TBS, and centrifuged in an SW40 rotor (38,000 rpm, 2 h, 4°C). The virus pellet was suspended in TBS by sonication. CsCl was added to a density of 1.37 g/ml, and the virus particles were centrifuged to isopycnic equilibrium in an SW50.1 rotor (35,000 rpm, 18 h, 4°C). Visible virus bands were collected by side puncture, desalted by using a Centricon 30 (Amicon Corp.), and scanned from 220 to 360 nm with a Beckman DU-6 spectrophotometer.
ADRV was purified directly from infected stool specimens diluted 1:5 with TBS. After the addition of Zwittergent 3-14 (Calbiochem-Behring) to 0.5% and extraction with Genetron, virus was pelleted in a type 45Ti rotor (40,000 rpm, 60 min, 4°C). The virus was suspended and centrifuged through a 25% sucrose cushion at 35,000 rpm for 100 min at 4°C in an SW40 rotor. The suspended virus was layered on top of a preformed metrizamide gradient (Accurate Chemical and Scientific) (20 to 50% [wt/vol]) in TBS and centrifuged at 45,000 rpm for 7 h (4°C) in an SW50.1 rotor. Bands containing virus were collected and desalted with a Centricon 30. To obtain highly purified virions, the concentrated virus was centrifuged through a preformed sucrose gradient (20 to 40%
[wt/wt]) in TBS at 20,000 rpm for 3.9 h (5°C) in an SW40 rotor. The virus band was collected as described above.
Virus density was measured in CsCl, with suspended virus spun to equilibrium in a density gradient (1.37 g/ml) at 4°C as described for group A rotavirus. 20 
RESULTS
Characterization of purified virions. ADRV has the same distinctive morphology as group A rotavirus, with a doubleshelled capsid and spikes arranged in wheel-like fashion (Fig. 1) . The complete particle measures -70 nm in diameter, single-shelled viral particles purified in CsCl gradient after EDTA treatment are -60 nm in diameter, and viral cores prepared by CaCl2 treatment of single-shelled particles have a hexagonal outline with a diameter of -47 nm.
By isopycnic centrifugation in CsCl, complete viral particles banded at a density of 1.373 g/ml and single-shelled particles banded at 1.435 g/ml (Fig. 2) . Freshly prepared double-shelled virus had a maximum UV absorption at 259 nm and a minimum UV absorption at 247 nm, and singleshelled particles had a maximum UV absorption at 259 nm and a minimum UV absorption at 244 nm (Fig. 3) . These values are identical to the values observed with the group A rotavirus. The ratio of UV absorbance at 260 nm to that at 280 nm (A260/A280), an indicator of RNA content, was -1.43 for double-shelled particles and --1.49 for single-shelled particles.
ADRV structural polypeptides. The structural polypeptides of ADRV were examined by SDS-PAGE, and their molecular weights were estimated by direct comparison with reference markers and with group A rotavirus controls electrophoresed in companion lanes (Fig. 4) was associated with the loss of three polypeptides with molecular masses of 64, 61, and 41 kDa (Fig. 4) probed with acute-phase or preimmune sera (lanes A) or with convalescent-phase human sera or hyperimmune serum (lanes C) and then developed with peroxidase-conjugated complexes and diaminobenzidine. Positive control (lanes P) was a human convalescent-phase serum with 10-to 20-fold-higher titer than paired convalescent-phase sera (lane C). Human sera to group A rotavirus (group A lanes) was obtained from the recipient of rhesus rotavirus vaccine. Guinea pig sera were obtained pre-and postimmunization with SAlI. Human sera to ADRV (group B lanes) were obtained from two patients recovering from recent infection. dase digestion of purified ADRV resulted in deglycosylation of the 41-kDa polypeptide, similar to the deglycosylation of the VP7 of SAl (Fig. 6) . In ADRV, two deglycosylated proteins with apparent molecular masses of 35 kDa appeared.
Western blot analysis of antigenic polypeptides of ADRV. The viral polypeptides were separated by SDS-PAGE, electrotransferred onto nitrocellulose membranes, and probed with human and animal sera or monoclonal antibodies (Fig.  5) . All of the structural proteins were detected when probed with a high-titer convalescent-phase human serum (lane P), indicating the antigenicity of the structural polypeptide. With human sera, a strong reaction to the 113-kDa polypeptide with both the acute-and the convalescent-phase sera was observed while polypeptides of molecular sizes 47 and 41 kDa were ADRV polypeptides which differed between infected patients (lanes Cl and C2), as evidenced by the different ratio of the serum responses to the 47-versus 41-kDa polypeptides. Rabbit hyperimmune serum prepared from ADRV responded to the 113-, 47-and 41-kDa polypeptides as well as to a few other proteins. Similar results were observed in guinea pig antisera prepared against group A rotavirus.
The titer of convalescent-phase serum of one patient was determined to endpoint (Fig. 7) . Antibody to the 47-kDa protein was present in highest titer (1:1,000), antibody to the 113-kDa protein was present in an intermediate titer (1:200) , and antibodies to the 136-, 64-and 41-kDa proteins were present at the starting dilution (1:100).
Antisera raised against a variety of animal group B rotaviruses and tested in 1:200 dilution against human ADRV demonstrated strong reactivity to the 47-kDa polypeptide and some reactivity to the 113-kDa polypeptide (Fig. 8) . Guinea pig antisera raised against ADRV, however, reacted strongly with all the viral polypeptides. None Other polypeptides of ADRV located in viral cores have been identified, assigned approximate molecular sizes, and given a tentative protein designation on the basis of the control preparation of SAl. These include the 136-kDa polypeptide, proposed to be VP1, a 113-kDa structural polypeptide, proposed to be VP2, and several proteins within the range of 100 to 72 kDa which may be VP3, VP4, or related products.
As determined by Western blot analysis, all the viral proteins are antigenic when tested with high-titer sera (1: 100). As the titer of convalescent-phase sera rose, antibodies to the 47-kDa polypeptide appeared at highest titer, with antibodies to the 113-, 64-, and 41-kDa polypeptides present at intermediate titers. The ratio of the antibody response to the 47-and 41-kDa polypeptides differed markedly between patients, suggesting a parallel with the dissociation of antibody responses to group A rotavirus between inner-capsid antigen tested by enzyme-linked immunosorbent assay and outer capsid antigen tested as a neutralization response.
The lack of cross-reactivity between antisera to group A and group B rotaviruses has been reported previously in studies using immunoelectron microscopy, immunofluorescence, and enzyme-linked immunosorbent assays (17, 20, 21) . These studies suggest that these two viruses, though in the same family, are antigenically quite distinct. Our data extend these observations by examining individual proteins by Western blot. Initially, ADRV was hypothesized to have emerged by simple reassortment of human group A rotavirus with animal strains of group B rotavirus. The lack of cross-reactivity to the individual proteins suggests that major antigenic differences that we observed reflect a greater diversity of the polypeptides.
Efforts at understanding the biology and the origin of the non-group A rotaviruses, considerations of immunogenicity and control with vaccines, and improved diagnosis of this noncultivable agent will require identification of the genes encoding the inner and outer capsid proteins. This study has identified the structural proteins of these capsid structures and provides a basis for determining the gene-coding assignments for these proteins.
